Guardant Health (GH) Receivables - Net (2017 - 2026)

Guardant Health has disclosed Receivables - Net across 10 years of filings, most recently posting $144.2 million for Q2 2026.

• In Q2 2026, Receivables - Net rose 10.75% year-over-year to $144.2 million; the TTM figure through Jun 2026 stood at $144.2 million (up 10.75% YoY), while the FY2025 annual figure was $137.8 million, up 25.03% from the prior year.
• Receivables - Net came in at $144.2 million for Q2 2026 at Guardant Health, up from $137.4 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $144.2 million in Q2 2026 to a low of $84.3 million in Q1 2022.
• Average Receivables - Net over 5 years is $104.4 million, with a median of $96.3 million recorded in 2022.
• Year-over-year, Receivables - Net surged 77.53% in 2022 and slipped 9.24% in 2023.
• Over 5 years, Receivables - Net stood at $97.3 million in 2022, then slipped by 8.71% to $88.8 million in 2023, then rose by 24.18% to $110.3 million in 2024, then advanced by 25.03% to $137.8 million in 2025, then increased by 4.64% to $144.2 million in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $144.2 million in Q2 2026, $137.4 million in Q1 2026, and $137.8 million in Q4 2025.